Topical vaginal microbicides in HIV/STI prevention
Chirenje, Z.M.
Central African Journal of Medicine 47(8): 209-210
2001
ISSN/ISBN: 0008-9176 PMID: 12808769 Document Number: 250714
Document emailed within 1 workday
Related Documents
Chirenje, Z.M. 2001: Topical vaginal microbicides in HIV/STI prevention Central African Journal of Medicine 47(8): 209-210Moon, M.W.; Khumalo-Sakutukwa, G.N.; Heiman, J.E.; Mbizvo, M.T.; Padian, N.S. 2002: Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say Journal of Transcultural Nursing: Official Journal of the Transcultural Nursing Society 13(1): 19-23
Van Damme, L. 2000: Clinical research with topical microbicides as a potential HIV prevention method Aids Reader 10(9): 552-554
1999: Vaginal microbicides needed for female-controlled prevention Contraceptive technology update 20(3): 25-27
Sánchez-Rodríguez, J.; Vacas-Córdoba, E.; Gómez, R.; De La Mata, F.Javier.; Muñoz-Fernández, M.Ángeles. 2015: Nanotech-derived topical microbicides for HIV prevention: the road to clinical development Antiviral Research 113: 33-48
de Zoysa, I.; Elias, C.J.; Bentley, M.E. 1998: Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention American Journal of Public Health 88(4): 571-575
Abner, S.R.; Guenthner, P.C.; Guarner, J.; Hancock, K.A.; Cummins, J.E.; Fink, A.; Gilmore, G.Thomas.; Staley, C.; Ward, A.; Ali, O.; Binderow, S.; Cohen, S.; Grohskopf, L.A.; Paxton, L.; Hart, C.E.; Dezzutti, C.S. 2005: A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection Journal of Infectious Diseases 192(9): 1545-1556
Abdulai, M.A.; Baiden, F.; Adjei, G.; Afari-Asiedu, S.; Adjei, K.; Tawiah, C.; Newton, S. 2012: An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana Bmc Women's Health 12: 40
Abdulai, M.A.; Baiden, F.; Adjei, G.; Afari-Asiedu, S.; Adjei, K.; Tawiah, C.; Newton, S. 2012: An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana Bmc Women's Health 12: 40
Fabio, S. di; Cianfriglia, M.; Flego, M.; Ascione, A.; Gellini, M.; Zamboni, S.; Binelli, A.; Carlini, F.; Germinario, E.; Vella, S. 2006: Animal HU-SCID model of vaginal transmission of HIV-1 for the preclinical evaluation of microbicides. Development of peptidomimetics and mini-antibodies as a new class of microbicides of biotechnological origin Rapporti ISTISAN Istituto Superiore di Sanita (06/50): 298-301
McCormack, S.; Ramjee, G.; Kamali, A.; Rees, H.; Crook, A.M.; Gafos, M.; Jentsch, U.; Pool, R.; Chisembele, M.; Kapiga, S.; Mutemwa, R.; Vallely, A.; Palanee, T.; Sookrajh, Y.; Lacey, C.J.; Darbyshire, J.; Grosskurth, H.; Profy, A.; Nunn, A.; Hayes, R.; Weber, J. 2010: PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial Lancet 376(9749): 1329-1337
Keller, M.J.; Klotman, M.E.; Herold, B.C. 2003: Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus American Journal of Reproductive Immunology 49(5): 279-284
Guffey, M.Bradford.; Richardson, B.; Husnik, M.; Makanani, B.; Chilongozi, D.; Yu, E.; Ramjee, G.; Mgodi, N.; Gomez, K.; Hillier, S.L.; Karim, S.Abdool.; Black, R.; Soto-Torres, L.; Estep, S.; Profy, A.; Moench, T.; Karim, S.; Taha, T.; Kumwenda, N.; Makanani, B.; Hurst, S.; Nkhoma, C.; Kachale, E.; Ramjee, G.; Govinden, R.; Coumi, N.; Dladla-Qwabe, N.; Ganesh, S.; Morar, N.; Chirenje, Z.; Padian, N.; van der Straten, A.; Magure, T.; Mlingo, M.; Mgodi, N.; Hoffman, I.; Martinson, F.; Tembo, T.; Chinula, L.; Mvalo, T.; Parham, G.; Kapina, M.; Reid, C.; Kasaro, M.; Brahmi, A.; Maslankowski, L.; Prince, J.; Tustin, N.; Whittington, S.; Yu, E.; Cates, W.; Coletti, A.; Gomez, K.; White, R.; Cian 2014: HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women Sexually Transmitted Infections 90(5): 363-369
Zewdie, D.; Holschneider, S. 2001: Microbicides 2000 conference. Welcoming remarks. Expanding our prevention options: the role of the international community in providing an enabling environment for microbicides Aids 15 Suppl. 1: S5-S6
Zewdie, D.; Holschneider, S. 2001: Microbicides 2000 conference. Welcoming remarks. Expanding our prevention options: the role of the international community in providing an enabling environment for microbicides Aids 15 Suppl. 1: S5-S6
Dhawan, D.; Keller, M.; Klotman, M.E. 2006: Topical microbicides: the time has come Aids Reader 16(3): 144-148; 155-158 161; Discussion 148: 156-157
Woodsong, C. 2004: Covert use of topical microbicides: implications for acceptability and use Perspectives on Sexual and Reproductive Health 36(3): 127-131
Moore, J.P. 2005: Topical microbicides become topical New England Journal of Medicine 352(3): 298-300
Mauck, C.; Rosenberg, Z.; Van Damme, L. 2001: Recommendations for the clinical development of topical microbicides: an update Aids 15(7): 857-868
Darroch, J.E.; Frost, J.J. 1999: Women's interest in vaginal microbicides Family Planning Perspectives 31(1): 16-23